Trader: Low Volume ...
Health Care: Drugs
Cyclacel Pharmaceuticals Inc. (CYCC: NASDAQ)
$0.52 -0.07 | -11.86%
06/04/12 - 03:59 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 24.45M | 29.50M | 11.49M | 24.22M |
| Receivables | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 182.00K | 174.00K | 145.00K | 508.00K |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 25.83M | 31.05M | 13.37M | 29.01M |
| Property, Plant & Equipment, Gross | 8.37M | 8.39M | 10.03M | 9.75M |
| Accumulated Depreciation & Depletion | 8.20M | 7.98M | 9.13M | 8.00M |
| Property, Plant & Equipment, Net | 167.00K | 408.00K | 901.00K | 1.75M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 0.00 | 0.00 | 196.00K | 195.00K |
| Total Non-Current Assets | 167.00K | 408.00K | 1.10M | 1.94M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 26.00M | 31.46M | 14.47M | 30.96M |
| Accounts Payable | 1.76M | 1.72M | 3.16M | 754.00K |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 71.00K | 680.00K | 2.53M | 1.66M |
| Total Current Liabilities | 6.50M | 6.54M | 9.82M | 8.63M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 626.00K |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 1.06M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 1.69M |
| Total Liabilities | 6.50M | 6.54M | 9.82M | 10.32M |
| Preferred Stock Equity | 1.00K | 1.00K | 2.00K | 2.00K |
| Common Stock Equity | 19.50M | 24.92M | 4.64M | 20.64M |
| Common Par | 54.00K | 47.00K | 26.00K | 20.00K |
| Additional Paid In Capital | 276.45M | 266.67M | 226.88M | 223.38M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -257.06M | -241.82M | -222.28M | -202.72M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 57.00K | 31.00K | 20.00K | -42.00K |
| Total Capitalization | 19.50M | 24.92M | 4.64M | 21.27M |
| Total Equity | 19.50M | 24.92M | 4.64M | 20.64M |
| Total Liabilities & Stock Equity | 26.00M | 31.46M | 14.47M | 30.96M |
| Total Common Shares Outstanding | 54.22M | 46.56M | 25.74M | 20.43M |
| Preferred Shares | 1.21M | 1.21M | 2.05M | 2.05M |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 50.30M | 37.84M | 22.20M | 20.43M |
| Diluted Weighted Shares Outstanding | 50.30M | 37.84M | 22.20M | 20.43M |
| Number of Employees | 18 | 18 | 24 | 51 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with CYCC
- Portfolio NameUser Type
- Uservlady 1
- Contributor13 Biotech Stocks Bought an...
- ProWilbur Ross - Invesco Priva...
- Contributor10 Cheap Biotech Stocks Tha...
- Userjeezlola
- Contributor10 Biotech Stocks Expected ...
- UserJSD Holdings
- UserBesV Portfolio 1
- UserStock2009
- UserTdawg
Latest CYCC Headlines from TheStreet
- Friday's Top 10 Articles, Videos on TheStreet 03.02.12 | 01:03 pm
- Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash 03.02.12 | 05:03 am
- BIO CEO Conference Live Blog 02.13.12 | 01:02 pm
- The Worst Biotech CEO of 2011 Is ... 12.09.11 | 07:12 am
- The Biotech Stock 13F Review: What Hedge Funds Were Buying and Selling 11.16.11 | 08:11 am
- Biotech Stock Mailbag: Somaxon, Transcept 10.07.11 | 06:10 am
- Biotech Stock Mailbag: Research Backs Shorting Micro-Cap Cancer Drug Stocks 09.30.11 | 05:09 am
- Biotech Stock Mailbag: Cyclacel Pharma 08.12.11 | 05:08 am
- Cyclacel Stock Gaps Down On Today's Open (CYCC) 08.08.11 | 10:08 am
- Biotech Stock Mailbag: Ranking Cheap Biotechs 07.01.11 | 08:07 am
Press Releases for CYCC
Partner Headlines for CYCC
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3 - Seeking Alpha 05.25.12 | 08:05 pm
- Cyclacel: An Intriguing Long Shot - Seeking Alpha 03.20.12 | 08:03 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 11.18.11 | 09:11 am
- Buy And Sell Ideas Based On Wednesday's Big News And Price Decliners - Seeking Alpha 09.29.11 | 08:09 am
- The Biotech Bump: Cyclacel Pharmaceuticals - Benzinga 07.28.11 | 01:07 pm
- Profit From These 3 Analysts' Stock Picks for Under $10 - Seeking Alpha 07.13.11 | 09:07 am
- Cyclacel Pharmaceuticals Files S-3 $75M Mixed Securities Shelf - Benzinga 04.04.11 | 04:04 pm
- US scientists recreate heart defect in a lab dish - Reuters 02.09.11 | 01:02 pm
- Pfizer, Adolor End Collaboration to Develop Pain Meds: Biotech's Latest Troubles - Seeking Alpha 12.26.10 | 01:12 am
